PROT# 6517-CL-0020: A Phase 3b Randomized, Double-Blind, Placebo Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of Vernakalant Hydrochloride Injection in Patients with Recent Onset Symptomatic Atrial Fibrillation

Project: Research project

Project Details

StatusFinished
Effective start/end date7/16/107/16/13

Funding

  • Astellas Pharma Global Development, Inc. (Prot # 6517-CL-0020)